03-01-2018 11:22 AM CET - Health & Medicine

Macular Edema Key Players - ActiveSite Pharmaceuticals Inc, Coherus BioSciences Inc, Lupin Ltd, and Mabion SA Market Analysis & Forecast to 2024

Press release from: WiseGuy Research consultants Pvt Ltd.
Macular Edema 
Macular Edema 

Macular Edema 


Macular edema is swelling or fluid retention in a specialized part of the retina called the macula. Symptoms of macular edema include blurred or wavy central vision and/or colors appear changed. There are many causes of macular edema. It is frequently associated with diabetes, where damaged blood vessels in the retina begin to leak fluids, including small amounts of blood, into the retina. Other causes include Macular Edema, side effects of certain medications and certain genetic disorders, such as retinoschisis or retinitis pigmentosa.

Click here for sample report @ www.wiseguyreports.com/sample-request/2593469-macular-ede...

Top Companies mentioned

ActiveSite Pharmaceuticals Inc

Coherus BioSciences Inc

Lupin Ltd

Mabion SA

OMEICOS Therapeutics GmbH

Macular Edema Industry Major Outlook

Pharmaceutical and Healthcare latest pipeline guide Macular Edema   - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Macular Edema  , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Macular Edema (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Macular Edema and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Preclinical and Discovery stages are 1, 7 and 2 respectively.

Macular Edema pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Macular Edema - Competitive Analysis

Key players are making innovative developments in Macular Edema industry.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector


The pipeline guide provides a snapshot of the global therapeutic landscape of Macular Edema.

The pipeline guide reviews pipeline therapeutics for Macular Edema by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Macular Edema therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Macular Edema therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects. 

The pipeline guide reviews latest news related to pipeline therapeutics for Macular Edema.


For Detailed Reading Please visit @ www.wiseguyreports.com/reports/2593469-macular-edema-pipe...

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.
News-ID: 962329 • Views: 371
More releasesMore releases

You can edit or delete your press release here: